Top compounds associated with response to LYZ


Feature Type Standardized
Nominal ANOVA
mRNA VNLG/124 GDSC1000 pan-cancer AAC 0.31 1e-19
mRNA AZD6244 CCLE pan-cancer AAC 0.38 8e-17
mRNA PD-0325901 CCLE pan-cancer AAC 0.35 6e-15
mRNA CI-1040 GDSC1000 pan-cancer AAC 0.27 7e-15
mRNA RDEA119 GDSC1000 pan-cancer AAC 0.25 2e-14
mRNA AC220 GDSC1000 pan-cancer AAC 0.27 7e-14
mRNA PD-0325901 GDSC1000 pan-cancer AAC 0.24 7e-13
mRNA linifanib GDSC1000 pan-cancer AAC 0.26 1e-12
mRNA Sorafenib GDSC1000 pan-cancer AAC 0.34 4e-10
mRNA Sunitinib GDSC1000 pan-cancer AAC 0.32 1e-09
Download CSV